Abstract Objective: To estimate the possible existing anti-pressor effect of oral potassium chloride supplementation for short term chronic salt loading induced blood pressure rising through diet intervention.
P-601 ESSENTIAL HYPERTENSION AS A RESULT OF INCREASED EXPOSURE TO HIGH GRAVITATIONAL STRESS ASSOCIATED WITH REGULAR PROLONGED SITTING TYPICAL FOR MODERN LIFESTYLE
Space flight studies demonstrated that increase of gravitational stress(GS) after prolonged microgravity causes sympathetic activation, water retention and arterial pressure increase -the process so similar to essential hypertension(EH) as if EH were an advanced stage of that adaptive response to some further increase of GS.
To create a hypothesis that typical for modern lifestyle prolonged sitting increases GS and may cause development of arterial hypertension.
The theory of gravitational physics was applied to human cardiovascular physiology and model of antigravitational response of the system was developed. Then literature was searched to find clinical and experimental data supporting the theoretically predicted model.
Gravitation shifts blood downwards, and gravitational stress (GS) on the cardiovascular system in upright position may be defined as amount of work necessary to return blood upwards and maintain adequate upperbody circulation calculated as the product of the gravitational potential (U gr ϭg*h) and the mass of blood shifted by gravitation: GSϭU gr *M shift . Blood in complex vascular net redistributes slowly and M shift actually is a function of time, defined at first approximation as M shift (t)ϭ(U gr *t)/R d (where R d -resistance to downward blood flow) then GSϭU gr * M shift (t)ϭ(U gr 2 *t)/R d ϭ(g 2 *h 2 *t)/R d . Human CV system has mechanism of defense against GS preventing gravitation-induced downward blood shift in upright posture -calf muscle pump(CMP). With regular calf contractions CMP pumps blood out of the lower parts of the body and GSϭ(g 2 *h 2 *t)/R d -Wcalf(where W calf -work of the CMP). From this analysis, typical of modern life regular, prolonged sitting with significant body height and completely inactivated CMP (W calf ϭ0) should cause significant increase of gravitational stress on the cardiovascular system, requiring advanced antigravitational response with sympathetic hyperactivity, vasoconstriction, volume overload and arterial hypertension. The hypertensive effect of prolonged sitting has been demonstrated in clinical studies.
Thus, scientifically sound hypothesis was developed that explains essential hypertension as result of increased exposure to high gravitational stress and offers inexpensive way to its complete healing through elimination of its primary factor of prolonged sitting. Although recent consensus guidelines have stressed the importance of simultaneous management of multiple cardiovascular risk factors, the actual effects of such strategies have not been adequately tested. The Respond study assessed the efficacy of concurrent treatment of concomitant hypertension/dyslipidemia.
Respond is a double-blind, double-dummy, placebo-controlled trial undertaken in 15 countries, which randomized 1,660 patients with hypertension and dyslipidemia to 1 of 15 combinations of amlodipine (placebo, 5, or 10 mg) and atorvastatin (placebo, 10, 20, 40, 80 mg) . The main efficacy assessment was the mean change from baseline to end point in systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C). A key secondary analysis was change from baseline to end point in Framingham risk score in patients without coronary heart disease (CHD) or a risk equivalent (n ϭ 861).
At 8 weeks, combination-treated patients experienced dose-related and statistically significant reductions in SBP, LDL-C, and Framingham risk score, resulting in 7.7-11.2 mean percentage point reductions at end point (from mean baseline levels of 15.8-18.5%) in the estimated 10-year risk of developing CHD (Table) .
Simultaneous treatment of concomitant hypertension/dyslipidemia with amlodipine/atorvastatin is a highly effective strategy for reducing Framingham risk score. 
